The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board, resolving to pay a dividend of EUR 0.22 per share for the 2025 fiscal year, representing a significant increase from the previous year's EUR 0.17 per share. This decision underscores the company's continued financial strength and commitment to shareholder value.
As in previous years, the Annual General Meeting was held as an in-person event near the company's headquarters in Berlin. In total, 55.37% of the company's share capital was represented. The meeting endorsed the actions of the Executive Board and Supervisory Board for the 2025 fiscal year and approved all items on the agenda by a large majority, reflecting strong shareholder confidence in management.
The detailed voting results of the Annual General Meeting and the CEO's presentation are available on the Eckert & Ziegler SE website at https://www.ezag.com/investors/annual-general-meeting/.
Eckert & Ziegler SE, with more than 1,000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares are listed in the TecDAX index of Deutsche Börse.
The increased dividend signals the company's robust financial health and its ability to generate strong cash flows, even as it continues to invest in growth opportunities within the radiopharmaceutical sector. This announcement is particularly significant given the company's strategic position in the critical field of nuclear medicine, where demand for innovative therapies and diagnostic solutions is rising globally. The dividend hike also reflects the board's confidence in future earnings prospects and its commitment to returning value to shareholders.
For investors, the higher dividend yield makes Eckert & Ziegler shares more attractive, particularly in a low-interest-rate environment. The company's inclusion in the TecDAX index further underscores its standing as a technology-driven growth company. The strong shareholder turnout and overwhelming approval of all agenda items indicate solid support for the current strategy and management.
